Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP563375.RAemZw-M-YNTreJokJCMTXefafC7vC4xKOusuOCCYR448130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP563375.RAemZw-M-YNTreJokJCMTXefafC7vC4xKOusuOCCYR448130_provenance.
• NP298618.RAfewCssNP_rJp58vdjAZ58AHfFM9ZxJnrH7nSCoYEMGg130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP298618.RAfewCssNP_rJp58vdjAZ58AHfFM9ZxJnrH7nSCoYEMGg130_provenance.
• NP716463.RAAjX42oXeEfaytvlArqxrwNBoP43m2I9okUFLD0UcuLQ130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP716463.RAAjX42oXeEfaytvlArqxrwNBoP43m2I9okUFLD0UcuLQ130_provenance.
• NP558662.RArVrEnkUcRR4sWZgQNdqk8ZkYxFSSsv3u4eynQCgyRBs130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP558662.RArVrEnkUcRR4sWZgQNdqk8ZkYxFSSsv3u4eynQCgyRBs130_provenance.
• NP575267.RAkMHEJzo6KJowNNjdIFTKY5GVoFDvBWVQoWWcnti0Aaw130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP575267.RAkMHEJzo6KJowNNjdIFTKY5GVoFDvBWVQoWWcnti0Aaw130_provenance.
• NP573233.RAYuLltyHCF3FJqTJqno4uPcqzHMQIsphS1Fq01i8V0_U130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP573233.RAYuLltyHCF3FJqTJqno4uPcqzHMQIsphS1Fq01i8V0_U130_provenance.
• NP447779.RAwzmPxdvMw5W_NaNgBDvNSh0Ayc6dBQ6_1Ag5gokoQak130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP447779.RAwzmPxdvMw5W_NaNgBDvNSh0Ayc6dBQ6_1Ag5gokoQak130_provenance.
• assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP300211.RA5KKDqU33jLfyl_PaE6CnVAiThdfut7bSy_p8xJja1kk130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300211.RA5KKDqU33jLfyl_PaE6CnVAiThdfut7bSy_p8xJja1kk130_provenance.
• NP816424.RA7HJj6nHXTyaffzzImWr62a149lwFPWKwfJtwaWCp0kY130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP816424.RA7HJj6nHXTyaffzzImWr62a149lwFPWKwfJtwaWCp0kY130_provenance.
• NP392659.RAT5kMk6RMyjRf3wXoRyijZEL5PaNLxBUoZWDZdqN9TvA130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP392659.RAT5kMk6RMyjRf3wXoRyijZEL5PaNLxBUoZWDZdqN9TvA130_provenance.
• NP670943.RARJ_reFpMSben0BEpjyiJsQ-gDD1XE1jn6iEkJEclWx8130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP670943.RARJ_reFpMSben0BEpjyiJsQ-gDD1XE1jn6iEkJEclWx8130_provenance.
• assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP272117.RAq9kLsm-pCJ6Zxk2M2wNw6_5h4L1CdIIvVl1ZhEpFNi8130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP272117.RAq9kLsm-pCJ6Zxk2M2wNw6_5h4L1CdIIvVl1ZhEpFNi8130_provenance.
• NP272484.RAnIBdLqFHfZcpdwXbsra3hwOE2VWOCKiUSO46KwUy74o130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP272484.RAnIBdLqFHfZcpdwXbsra3hwOE2VWOCKiUSO46KwUy74o130_provenance.
• NP696360.RAIXr8oQwLXUjb4csXzBvY0BfEpBDO8zjbmZFq7ULjzYI130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP696360.RAIXr8oQwLXUjb4csXzBvY0BfEpBDO8zjbmZFq7ULjzYI130_provenance.
• NP652990.RAnK_FTFGTGaWO1KpOgsl00hqfx_5OWVQbC9VIWrs7pl8130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP652990.RAnK_FTFGTGaWO1KpOgsl00hqfx_5OWVQbC9VIWrs7pl8130_provenance.
• NP653050.RADW1F16CkUnBAKZccvMfNJPN5g-OE1ZGHZuT-1LklYQY130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP653050.RADW1F16CkUnBAKZccvMfNJPN5g-OE1ZGHZuT-1LklYQY130_provenance.
• NP945733.RAds48PJmiBVRP4ltPZ31IbzxqDLn4AHgKqjYZ3UPi_3o130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945733.RAds48PJmiBVRP4ltPZ31IbzxqDLn4AHgKqjYZ3UPi_3o130_provenance.
• NP945742.RASqYaP-EEIbO3F_vSid2TaRtZTq_UErbCcfcfWaNUXZo130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945742.RASqYaP-EEIbO3F_vSid2TaRtZTq_UErbCcfcfWaNUXZo130_provenance.
• NP945731.RADiWhbjUUzImFYcVDokGTP7028sf8FdZUe7tM5XnL0RE130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945731.RADiWhbjUUzImFYcVDokGTP7028sf8FdZUe7tM5XnL0RE130_provenance.
• NP788572.RAhX64CxM73CHf30Eijvto3noGBrU6l6thOTfLDHPRhFc130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP788572.RAhX64CxM73CHf30Eijvto3noGBrU6l6thOTfLDHPRhFc130_provenance.
• NP945735.RAsV__P6HDWk6FDdv7C4d4UFtF3JX6xzFgT8pMUCr5RJM130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945735.RAsV__P6HDWk6FDdv7C4d4UFtF3JX6xzFgT8pMUCr5RJM130_provenance.
• NP945741.RApwJchrh5OWOwR1v0UoD8paZI8KS9vSm-tyBsHh6naNQ130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945741.RApwJchrh5OWOwR1v0UoD8paZI8KS9vSm-tyBsHh6naNQ130_provenance.
• NP392570.RAyh7PKHbanBQK6DOQVQTDm3IWnSpnCEYdUmIaLGMpFGs130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP392570.RAyh7PKHbanBQK6DOQVQTDm3IWnSpnCEYdUmIaLGMpFGs130_provenance.
• NP653475.RAN4G6iE5GwURkTyjiKOBU13vew4BKwftAe_PAtkvWE3c130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP653475.RAN4G6iE5GwURkTyjiKOBU13vew4BKwftAe_PAtkvWE3c130_provenance.
• NP671159.RAwGiOEJyPs3bndeXEg7mnGgNQ4WvuQBKykthwU_YwOlY130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671159.RAwGiOEJyPs3bndeXEg7mnGgNQ4WvuQBKykthwU_YwOlY130_provenance.
• NP653364.RAzUbYnS-tgRLhBbntPfdUyFH4rioKv6JJgHUmuTEHNEY130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP653364.RAzUbYnS-tgRLhBbntPfdUyFH4rioKv6JJgHUmuTEHNEY130_provenance.
• NP945732.RAGqC61bnAhb3-D3BfOGiDQNtqf7JByXWszVm3wS5jYuw130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945732.RAGqC61bnAhb3-D3BfOGiDQNtqf7JByXWszVm3wS5jYuw130_provenance.
• NP945734.RAOHguBrX59vFf6-98nmjLaLVl_TdZgj08hN3yPoZhTVk130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945734.RAOHguBrX59vFf6-98nmjLaLVl_TdZgj08hN3yPoZhTVk130_provenance.
• NP945736.RAHi0Dd6L4fAbqs6wxY5_BX6x_3DItQerwahyzX8UXB3c130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945736.RAHi0Dd6L4fAbqs6wxY5_BX6x_3DItQerwahyzX8UXB3c130_provenance.
• NP945738.RAIwCCY3-1JbHBgvDA8LftvkubRt_dClsqk-vBl-N0afU130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945738.RAIwCCY3-1JbHBgvDA8LftvkubRt_dClsqk-vBl-N0afU130_provenance.
• NP788517.RA2AdS-e57K07QUf7RidCzkiKaxNmlNxrFbqfDwxadIZ8130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP788517.RA2AdS-e57K07QUf7RidCzkiKaxNmlNxrFbqfDwxadIZ8130_provenance.
• NP945737.RA_q6PuDwQ2PANHAoX9RBh8SI6eRJ5HtfMWoTEgKfdDCM130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945737.RA_q6PuDwQ2PANHAoX9RBh8SI6eRJ5HtfMWoTEgKfdDCM130_provenance.
• NP945739.RA6bRvBLQKKVvixfKXqQVYpO6rJk9wrsyMkAKmlWu1frw130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945739.RA6bRvBLQKKVvixfKXqQVYpO6rJk9wrsyMkAKmlWu1frw130_provenance.
• NP945740.RAwk6XUgx9Th2NfZz7xqwZiu6YHb7XYTki3m4cVk-XZl4130_assertion description "[Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945740.RAwk6XUgx9Th2NfZz7xqwZiu6YHb7XYTki3m4cVk-XZl4130_provenance.